377 related articles for article (PubMed ID: 20421432)
1. Immunogenic tumor cell death for optimal anticancer therapy: the calreticulin exposure pathway.
Zitvogel L; Kepp O; Senovilla L; Menger L; Chaput N; Kroemer G
Clin Cancer Res; 2010 Jun; 16(12):3100-4. PubMed ID: 20421432
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death.
Panaretakis T; Kepp O; Brockmeier U; Tesniere A; Bjorklund AC; Chapman DC; Durchschlag M; Joza N; Pierron G; van Endert P; Yuan J; Zitvogel L; Madeo F; Williams DB; Kroemer G
EMBO J; 2009 Mar; 28(5):578-90. PubMed ID: 19165151
[TBL] [Abstract][Full Text] [Related]
3. Viral subversion of immunogenic cell death.
Kepp O; Senovilla L; Galluzzi L; Panaretakis T; Tesniere A; Schlemmer F; Madeo F; Zitvogel L; Kroemer G
Cell Cycle; 2009 Mar; 8(6):860-9. PubMed ID: 19221507
[TBL] [Abstract][Full Text] [Related]
4. Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress.
Martins I; Kepp O; Schlemmer F; Adjemian S; Tailler M; Shen S; Michaud M; Menger L; Gdoura A; Tajeddine N; Tesniere A; Zitvogel L; Kroemer G
Oncogene; 2011 Mar; 30(10):1147-58. PubMed ID: 21151176
[TBL] [Abstract][Full Text] [Related]
5. The n3-polyunsaturated fatty acid docosahexaenoic acid induces immunogenic cell death in human cancer cell lines via pre-apoptotic calreticulin exposure.
Molinari R; D'Eliseo D; Manzi L; Zolla L; Velotti F; Merendino N
Cancer Immunol Immunother; 2011 Oct; 60(10):1503-7. PubMed ID: 21779875
[TBL] [Abstract][Full Text] [Related]
6. Ecto-calreticulin in immunogenic chemotherapy.
Obeid M; Tesniere A; Panaretakis T; Tufi R; Joza N; van Endert P; Ghiringhelli F; Apetoh L; Chaput N; Flament C; Ullrich E; de Botton S; Zitvogel L; Kroemer G
Immunol Rev; 2007 Dec; 220():22-34. PubMed ID: 17979837
[TBL] [Abstract][Full Text] [Related]
7. Wogonin induced calreticulin/annexin A1 exposure dictates the immunogenicity of cancer cells in a PERK/AKT dependent manner.
Yang Y; Li XJ; Chen Z; Zhu XX; Wang J; Zhang LB; Qiang L; Ma YJ; Li ZY; Guo QL; You QD
PLoS One; 2012; 7(12):e50811. PubMed ID: 23251389
[TBL] [Abstract][Full Text] [Related]
8. ERP57 membrane translocation dictates the immunogenicity of tumor cell death by controlling the membrane translocation of calreticulin.
Obeid M
J Immunol; 2008 Aug; 181(4):2533-43. PubMed ID: 18684944
[TBL] [Abstract][Full Text] [Related]
9. Crosstalk between ER stress and immunogenic cell death.
Kepp O; Menger L; Vacchelli E; Locher C; Adjemian S; Yamazaki T; Martins I; Sukkurwala AQ; Michaud M; Senovilla L; Galluzzi L; Kroemer G; Zitvogel L
Cytokine Growth Factor Rev; 2013 Aug; 24(4):311-8. PubMed ID: 23787159
[TBL] [Abstract][Full Text] [Related]
10. A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death.
Garg AD; Krysko DV; Verfaillie T; Kaczmarek A; Ferreira GB; Marysael T; Rubio N; Firczuk M; Mathieu C; Roebroek AJ; Annaert W; Golab J; de Witte P; Vandenabeele P; Agostinis P
EMBO J; 2012 Mar; 31(5):1062-79. PubMed ID: 22252128
[TBL] [Abstract][Full Text] [Related]
11. Calreticulin exposure on malignant blasts predicts a cellular anticancer immune response in patients with acute myeloid leukemia.
Wemeau M; Kepp O; Tesnière A; Panaretakis T; Flament C; De Botton S; Zitvogel L; Kroemer G; Chaput N
Cell Death Dis; 2010 Dec; 1(12):e104. PubMed ID: 21368877
[TBL] [Abstract][Full Text] [Related]
12. Late-stage inhibition of autophagy enhances calreticulin surface exposure.
Li DD; Xie B; Wu XJ; Li JJ; Ding Y; Wen XZ; Zhang X; Zhu SG; Liu W; Zhang XS; Peng RQ
Oncotarget; 2016 Dec; 7(49):80842-80854. PubMed ID: 27825129
[TBL] [Abstract][Full Text] [Related]
13. Biphasic Increases of Cell Surface Calreticulin Following Treatment with Mitoxantrone.
Azuma Y; Suzuki K; Higai K; Matsumoto K; Tada S
Biol Pharm Bull; 2020 Oct; 43(10):1595-1599. PubMed ID: 32727970
[TBL] [Abstract][Full Text] [Related]
14. Reduction of endoplasmic reticulum Ca2+ levels favors plasma membrane surface exposure of calreticulin.
Tufi R; Panaretakis T; Bianchi K; Criollo A; Fazi B; Di Sano F; Tesniere A; Kepp O; Paterlini-Brechot P; Zitvogel L; Piacentini M; Szabadkai G; Kroemer G
Cell Death Differ; 2008 Feb; 15(2):274-82. PubMed ID: 18034188
[TBL] [Abstract][Full Text] [Related]
15. Calreticulin exposure dictates the immunogenicity of cancer cell death.
Obeid M; Tesniere A; Ghiringhelli F; Fimia GM; Apetoh L; Perfettini JL; Castedo M; Mignot G; Panaretakis T; Casares N; Métivier D; Larochette N; van Endert P; Ciccosanti F; Piacentini M; Zitvogel L; Kroemer G
Nat Med; 2007 Jan; 13(1):54-61. PubMed ID: 17187072
[TBL] [Abstract][Full Text] [Related]
16. Disruption of the PP1/GADD34 complex induces calreticulin exposure.
Kepp O; Galluzzi L; Giordanetto F; Tesniere A; Vitale I; Martins I; Schlemmer F; Adjemian S; Zitvogel L; Kroemer G
Cell Cycle; 2009 Dec; 8(23):3971-7. PubMed ID: 19901557
[TBL] [Abstract][Full Text] [Related]
17. The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death.
Panaretakis T; Joza N; Modjtahedi N; Tesniere A; Vitale I; Durchschlag M; Fimia GM; Kepp O; Piacentini M; Froehlich KU; van Endert P; Zitvogel L; Madeo F; Kroemer G
Cell Death Differ; 2008 Sep; 15(9):1499-509. PubMed ID: 18464797
[TBL] [Abstract][Full Text] [Related]
18. The nerve growth factor alters calreticulin translocation from the endoplasmic reticulum to the cell surface and its signaling pathway in epithelial ovarian cancer cells.
Vera CA; Oróstica L; Gabler F; Ferreira A; Selman A; Vega M; Romero CA
Int J Oncol; 2017 Apr; 50(4):1261-1270. PubMed ID: 28260038
[TBL] [Abstract][Full Text] [Related]
19. Immunogenic death of colon cancer cells treated with oxaliplatin.
Tesniere A; Schlemmer F; Boige V; Kepp O; Martins I; Ghiringhelli F; Aymeric L; Michaud M; Apetoh L; Barault L; Mendiboure J; Pignon JP; Jooste V; van Endert P; Ducreux M; Zitvogel L; Piard F; Kroemer G
Oncogene; 2010 Jan; 29(4):482-91. PubMed ID: 19881547
[TBL] [Abstract][Full Text] [Related]
20. eIF2α phosphorylation is pathognomonic for immunogenic cell death.
Bezu L; Sauvat A; Humeau J; Gomes-da-Silva LC; Iribarren K; Forveille S; Garcia P; Zhao L; Liu P; Zitvogel L; Senovilla L; Kepp O; Kroemer G
Cell Death Differ; 2018 Aug; 25(8):1375-1393. PubMed ID: 29358668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
